CMS certification 190064
Our Lady of the Lake Regional Medical Center
5000 Hennessy Blvd, Baton Rouge, LA 70808
Our Lady of the Lake Regional Medical Center has a CMS overall rating of 3 out of 5 stars. 73% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 24 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 2 and worse on 1. Emergency patients spend a median of 2 h 48 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 808 completed surveys, 21% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | LA | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 381 visits sampled · US median for EDs of the same volume: 3 h 21 min | 2 h 48 min | 2 h 9 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 20 visits sampled | 5 h 2 min | 3 h 54 min | 4 h 17 min |
| Left before being seen Lower is better · 210,156 patients | 1% | 2% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 23 patients | 74% | 70% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 726 patients | 75% | 69% | 65% |
How Our Lady of the Lake Regional Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Our Lady of the Lake Regional Medical CenterThis hospital | 3/5 | 73% | 2 h 48 min | 2 better 1 worse |
| Baton Rouge General Medical CenterSame city | 3/5 | 74% | 3 h 30 min | 4 better 1 worse |
| Surgical Specialty Center of Baton RougeSame city | Not rated | 88% | — | No different |
| The GeneralSame city | Not rated | 74% | 3 h | 1 better 1 worse |
| The Spine Hospital of LouisianaSame city | Not rated | 85% | — | No different |
| Ochsner Medical Center - Baton RougeSame city | 4/5 | 68% | 3 h 17 min | 1 better |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Baton Rouge.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 8,084 cases | Too few cases | 5.1% | 3.9% |
| Heart attack 168 cases | Too few cases | 13.5% | 11.9% |
| Heart failure 566 cases | Too few cases | 12.4% | 11.1% |
| Pneumonia 393 cases | Too few cases | 18.2% | 15.2% |
| Stroke 1,060 cases | Too few cases | 14.4% | 11.9% |
| COPD 133 cases | Too few cases | 10.8% | 8.6% |
| Heart bypass surgery (CABG) 146 cases | Too few cases | 2% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.85 likely 0.63 – 1.07 | 1 |
| After hip or knee replacement 47 cases | Too few cases | 5.9% | 4.1% |
| Deaths after a serious but treatable surgical complication 146 cases | No different | 201.44 per 1,000 likely 154.41 per 1,000 – 248.48 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 7,739 cases | No different | 0.18 per 1,000 likely 0 per 1,000 – 0.67 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 9,517 cases | No different | 0.22 per 1,000 likely 0.03 per 1,000 – 0.4 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 9,665 cases | No different | 0.19 per 1,000 likely 0.01 per 1,000 – 0.37 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 3,130 cases | No different | 3.47 per 1,000 likely 2.33 per 1,000 – 4.6 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,609 cases | No different | 0.97 per 1,000 likely 0 per 1,000 – 2.29 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,556 cases | No different | 9.27 per 1,000 likely 5.34 per 1,000 – 13.2 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 3,319 cases | No different | 4.54 per 1,000 likely 2.94 per 1,000 – 6.15 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,555 cases | No different | 4.6 per 1,000 likely 1.93 per 1,000 – 7.27 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 614 cases | No different | 1.47 per 1,000 likely 0.07 per 1,000 – 2.87 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,976 cases | No different | 0.8 per 1,000 likely 0 per 1,000 – 1.64 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 0.74 likely 0.43 – 1.19 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.38 likely 0.22 – 0.61 | 1 |
| Surgical site infections after colon surgery | No different | 0.64 likely 0.34 – 1.11 | 1 |
| MRSA bloodstream infections | No different | 0.77 likely 0.43 – 1.29 | 1 |
| C. diff intestinal infections | Better | 0.34 likely 0.24 – 0.47 | 1 |
1 more measure had too few cases here to report.
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 436 cases | Too few cases | 15.3% | 14.4% |
| Readmitted after heart failure 1,805 cases | Too few cases | 20.4% | 21.3% |
| Readmitted after pneumonia 977 cases | Too few cases | 17.6% | 17.3% |
| Readmitted after COPD 492 cases | Too few cases | 18.7% | 20% |
| Readmitted after heart bypass surgery 299 cases | Too few cases | 9.9% | 11% |
| Readmitted after hip or knee replacement 43 cases | Too few cases | 7.2% | 5.8% |
| Days back in hospital after a heart attack 183 cases | Too few cases | -16.2 days per 100 | — |
| Days back in hospital after heart failure 667 cases | Too few cases | -4.3 days per 100 | — |
| Days back in hospital after pneumonia 430 cases | Too few cases | -0.2 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 645 cases | No different | 12.3 per 1,000 likely 9.4 per 1,000 – 16.3 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 208 cases | No different | 9.1 per 100 likely 6.9 per 100 – 12 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 208 cases | No different | 4.3 per 100 likely 3 per 100 – 6.2 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 746 cases | No different | 1.1 likely 0.9 – 1.4 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
295 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 18 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Hospitalist | 80 |
| Nurse Anesthetist, Certified Registered | 35 |
| Internal Medicine | 33 |
| Physician Assistant | 29 |
| Family | 26 |
| Diagnostic Radiology | 20 |
| Emergency Medicine | 16 |
| Nurse Practitioner | 7 |
| Pharmacist | 6 |
| Physical Medicine & Rehabilitation | 5 |
| Anesthesiology | 4 |
| Nuclear Medicine | 4 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $437,903
- 2020 $604,590
- 2021 $508,707
- 2022 $636,079
- 2023 $1.1M
- 2024 $17.5M
- 2025 $695,629
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Gifts | $11,241 | 4 |
| Medical devices and supplies on long-term loan | $5,800 | 18 |
| Debt forgiveness | $2,089 | 4 |
| Speaking, teaching and other services | $500 | 1 |
| Space rental and facility fees | $500 | 1 |
| Food and beverage | $126 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Merck Sharp & Dohme LLC | $283,300 | 6 |
| Abbvie INC. | $67,194 | 9 |
| Amgen Inc. | $62,588 | 5 |
| E.R. Squibb & Sons, L.L.C. | $56,662 | 2 |
| Celgene Corporation | $47,571 | 2 |
| Bayer Healthcare Pharmaceuticals Inc. | $46,651 | 16 |
| Janssen Research & Development, LLC | $21,805 | 1 |
| AstraZeneca Pharmaceuticals LP | $20,747 | 3 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| An Open-label, Multicenter, Phase 3 Randomized, Active-Comparator-Controlled Clinical Study of Pembrolizumab MK-3475 in Combination With Sacituzumab … Merck Sharp & Dohme LLC | $140,217 |
| A Phase 3 Randomized Open-Label Study of Adjuvant Pembrolizumab With or Without MK-2870 in Participants With Resectable Stage II to IIIB N2 NSCLC not… Merck Sharp & Dohme LLC | $139,003 |
| Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) Wi… E.R. Squibb & Sons, L.L.C. · NCT06577441 | $53,312 |
| A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) versus Daratumumab, Bort… Celgene Corporation | $50,921 |
| Study Assessing Activity of Intravenous (IV) ABBV-383 Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refracto… ABBVIE INC. · NCT06158841 | $50,203 |
| A Phase 2 Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of AMG 193 in Subjects With Methylthioadenosine Phosphorylase (MT… Amgen Inc. | $24,606 |
| A Phase 3 Randomized Study Comparing Talquetamab in Combination with Pomalidomide (Tal-P), Talquetamab in Combination with Teclistamab (Tal-Tec), and… Janssen Research & Development, LLC | $21,805 |
| A Phase 3 Randomized, Open-label Trial of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd)… Karyopharm Therapeutics Inc. | $20,665 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Our Lady of the Lake Regional Medical Center
Is Our Lady of the Lake Regional Medical Center a good hospital?
Our Lady of the Lake Regional Medical Center has a CMS overall rating of 3 out of 5 stars. Of the 24 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 2 and worse on 1. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Our Lady of the Lake Regional Medical Center?
73% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 808 completed HCAHPS surveys.
How long is the wait in the Our Lady of the Lake Regional Medical Center emergency room?
Emergency patients spend a median of 2 h 48 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 1% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Our Lady of the Lake Regional Medical Center receive money from drug and device companies?
Drug and device makers reported $695,629 in payments to Our Lady of the Lake Regional Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.